CLINICAL_TRIALS
trial_result
· 2013-06-19
Clinical Trial Update: Rasagiline in the Treatment of Persistent Negative Symptoms of Schizophrenia [Phase 4]
Summary
Phase 4 clinical trial update evaluating rasagiline for persistent negative symptoms in schizophrenia; study completed with results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Maryland, Baltimore | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED | Results posted: 2013-06-19